PROCLARX

Welcome to the Brand page for “PROCLARX”, which is offered here for Vaccines; pharmaceutical and biopharmaceutical agents for the purpose of breaking down bacterial biofilms, which biofilms make bacteria resistant to the host immune system and to pharmaceutical antibiotics that in turn kill the bacteria; pharmaceutical and biopharmaceutical preparations and substances for the treatment of persistent bacterial infections, and chronic wounds;pharmaceutical, medical, scientific, and biopharmaceutical research and development; research, development, and testing of vaccines, antibodies, and other therapeutic pharmaceutical and biopharmaceutical agents;.

Its status is currently believed to be active. Its class is unavailable. “PROCLARX” is believed to be currently owned by “Lattice Biotech, LLC”.